Physician profile
Lance Terry Marr
NPI 1982745121
$323,277.32
in general payments reported to CMS, 2019-2025
27 companies · $48K in 2025
The $48K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,551 · 2020: $9,084 · 2021: $76K · 2022: $84K · 2023: $76K · 2024: $26K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $116K · Consulting Fee: $25K · Food and Beverage: $4,620 · Travel and Lodging: $4,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $116,187.50 |
| Consulting Fee | $24,500.00 |
| Food and Beverage | $4,620.39 |
| Travel and Lodging | $4,304.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $316,187.04 | 2020-2025 | Urolift, Barrigel |
| Neotract INC. | $4,119.31 | 2019-2020 | |
| Procept Biorobotics Corporation | $676.28 | 2019 | |
| Astellas Pharma US INC | $477.22 | 2019-2024 | Myrbetriq, Veozah |
| Abbvie INC. | $431.77 | 2019-2024 | |
| Boston Scientific Corporation | $156.57 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics |
| Calyxo, INC. | $154.69 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $145.20 | 2019-2023 | Aveed, Xiaflex |
| Pfizer INC. | $134.00 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $99.49 | 2025 | Gemtesa |
| Ferring Pharmaceuticals INC. | $97.84 | 2019-2025 | Adstiladrin |
| Accord Healthcare, INC. | $87.23 | 2024 | |
| Tolmar, INC. | $75.03 | 2024 | |
| Olympus America INC. | $63.88 | 2023-2025 | Itind System |
| Baxter Healthcare | $60.35 | 2023-2025 | Tisseel |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $44.42 | 2020 | |
| Allergan, INC. | $42.08 | 2019 | |
| Janssen Biotech, INC. | $40.07 | 2025 | Erleada |
| Axonics, INC. | $33.27 | 2023 | Axonics, Bulkamid |
| Vertex Pharmaceuticals Incorporated | $27.18 | 2025 | |
| Laborie Medical Technologies Corp. | $26.18 | 2023 | |
| Dendreon Pharmaceuticals LLC | $26.09 | 2020 | |
| Agiliti Surgical, INC. | $18.12 | 2019 | |
| Urovant Sciences INC | $16.00 | 2022 | |
| Therapeuticsmd, INC. | $14.43 | 2019 | |
| Travere Therapeutics, INC. | $11.82 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Marr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.